International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

November Blog: Approach to chemotherapy dosing in the obese child: an ongoing challenge

Jennifer Martin

This month we highlight a piece in the September Compass by Jessica Ryan and Jenny Martin, written on behalf of the TDM in Oncology Committee. It is an overview on approaches to chemotherapy dosing in the obese child that brings together data from several reviews. Clearance of some drugs is affected while for others it appears not to be. Further, adiposity may influence tumour responsiveness to chemotherapy. However, the authors highlight the lack of data specific to this special population which is becoming more prevalent.


Jessica Ryan and Jennifer Martin

University of Newcastle and Hunter New England Health

Newcastle, Australia

Interview with Sophie Stocker

Sophie Stocker

Sophie Stocker shares about her research aimed at answering clinically relevant questions, often posed in the course of work by hospital staff. Look out for two oral presentations of Sophie's contributed work at the congress, 'A time and motion study of phlebotomists’ work' and 'Vancomycin: Improving prescribing practices', as well as a presentation in the Symposium ‘Emerging TDM technologies and obstacles to widespread use’ on Wednesday (see preliminary program).


Sophie Stocker

Senior Scientific Officer, Department of Clinical Pharmacology & Toxicology, St Vincent’s Hospital

Conjoint Senior Lecturer, St Vincent’s Clinical School, University of NSW, Sydney, AU

Interview with Andrew McLachlan

Andrew McLachlan

It's a treat for me to hear from Andrew, who was one of my favourite lecturers during my Pharmacy studies at Sydney University, and certainly someone who contributed to my passion for research. Andrew shares about research work at the Faculty, where he is Dean, which combines in vitro, PKPB modelling and various types of clinical data to answer questions about drug interactions. Andrew will co-chair the ‘Translational science of antidoping – investigating pure performance’ symposium at the Congress on Tuesday (see preliminary program).


Andrew McLachlan

Head of School and Dean of Pharmacy

Sydney Pharmacy School

University of Sydney, AU

Interview with Indy Sandaradura

Indy Sandaradura

Indy Sandaradura shares how through the development of antimicrobial assays and new user-friendly Bayesian tools they have been able to improve clinical outcomes at his centre. Indy has worked very hard to ensure Young Scientists will have an excellent time at the congress through YS social and networking activities, and will co-chair the Young Scientist Symposium on Wednesday (see preliminary program).


Indy Sandaradura

Infectious Diseases Physician and Clinical Microbiologist, Westmead Hospital

Clinical Senior Lecturer, University of Sydney, AU

Page 12 of 24

The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.